overview
In terms of preventing infections associated with IV catheters, these guidelines (Part 1) provide guidance on best practices for preventing BSIs and other infections associated with peripherally inserted IV catheters. Masu. Meanwhile, the subsequent WHO guidelines (Part 2) are expected to be developed in 2024 and will also cover centrally inserted intravascular catheters. Specifically, Part 1 of the guidelines provides evidence-based guidance for the management (i.e., insertion, maintenance, access, and removal) of peripherally inserted intravascular catheters, including PIVCs, PICCs, and PACs, in three patient populations (adults, adolescents). This paper provides an overview of the proposed approach. – Pediatric and neonatal), during the provision of health care in all health care settings, including acute and long-term care facilities and primary care facilities.
The intended audience for these guidelines is clinicians (i.e., physicians, nurses, IPC specialists, etc.) involved in the management of patients requiring intravascular catheters. However, for proper and practical clinical compliance with the guidelines, hospital administrators and other professionals involved in healthcare must understand the importance of the guidelines and the focus of the recommendations, and ensure appropriate support for clinicians. need to do it. Patients are also part of the audience for these guidelines, as they generally need to be informed about the practices undertaken for their care and, in some cases, to understand the selection of interventions.